An improved lanthanum catalyst system for asymmetric amination: Toward a practical asymmetric synthesis of AS-3201 (ranirestat)

Organic Letters

Volumn 10, Issue 13, 2008, Pages 2725-2728

  Mashiko, Tomoyuki ^a   Kumagai, Naoya ^a   Shibasaki, Masakatsu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LANTHANUM; PYRAZINE DERIVATIVE; SPIRO COMPOUND; SX 3030;

AMINATION; ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; ISOLATION AND PURIFICATION; STEREOISOMERISM; SYNTHESIS;

AMINATION; CATALYSIS; LANTHANUM; MOLECULAR STRUCTURE; PYRAZINES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPIRO COMPOUNDS; STEREOISOMERISM;

EID: 51649090667     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol8008446     Document Type: Article

References (50)

1. (a) Diels, O. Justus Liebigs Ann. Chem. 1922, 429, 1.
2. (b) Diels, O.; Behncke, H. Chem. Ber. 1924, 57, 653.
3. (c) Evans, D. A.; Nelson, S. G. J. Am. Chem. Soc. 1997, 119, 6452.
4. (d) Evans, D. A.; Johnson, D. S. Org. Lett. 1999, 1, 595.
5. (e) Yamashita, Y.; Ishitani, H.; Kobayashi, S. J. Can. Chem. 2000, 78, 666.
6. (f) Ma, S.; Jiao, N.; Zheng, Z.; Ma, Z.; Lu, Z.; Ye, L.; Deng, Y.; Chen, G. Org. Lett. 2004, 6, 2193.
7. (a) Sestanj, K.; Bellini, F.; Fung, S.; Abraham, N.; Treasurywala, A.; Humber, L.; Simard-Duquesne, N.; Dvornik, D. J. Med. Chem. 1984, 27, 255.
8. (b) Kador, P. F.; Kinoshita, J. H.; Sharpless, N. E. J. Med. Chem. 1985, 28, 841.
9. (c) Lee, Y. S.; Pearlstein, R.; Kador, P. F. J. Med. Chem. 1994, 37, 787.
10. (d) Malamas, M. S.; Hohman, T. C.; Millen, J. J. Med. Chem. 1994, 37, 2043.
11. (e) Ishii, A.; Kotani, T.; Nagaki, Y.; Shibayama, Y.; Toyomaki, Y.; Okukada, N.; Ienaga, K.; Okamoto, K. J. Med. Chem. 1996, 39, 1924.
12. (a) Negoro, T.; Murata, M.; Ueda, S.; Fujitani, B.; Ono, Y.; Kuromiya, A.; Suzuki, K.; Matsumoto, J.-I. J. Med. Chem. 1998, 41, 4118.
13. (b) Kurono, M. Fujiwara, I, Yoshida, K. Biochemistry 2001, 40, 8216.
14. (c) Bril, V.; Buchanan, R. A. Diabetes Care 2004, 27, 2369.
15. (d) Kurono, M.; Fujii, A.; Murata, M.; Fujitani, B.; Negoro, T. Biochem. Pharmacol. 2006, 71, 338.
16. (e) Giannoukakis, N. Curr. Opin. Invest. Drugs 2006, 7, 916.
17. Nath, D.; Heemels, M.-T.; Anson, L. Nature 2006, 444, 83.
18. For selected examples, see: (a) Marigo, M.; Juhl, K.; Jørgensen, K. A. Angew. Chem., Int. Ed. 2003, 42, 1367.
19. (b) Sabby, S.; Bella, M.; Jørgensen, K. A. J. Am. Chem. Soc. 2004, 126, 8120.
20. (c) Pihko, P. M.; Pohjakallio, A. Synlett 2004, 2115.
21. (d) Ma, S.; Jiao, N.; Zheng, Z.; Ma, Z.; Lu, Z.; Ye, L.; Deng, Y.; Chen, G. Org. Lett. 2004, 6, 2193.
22. (e) Liu, X.; Li, H.; Deng, L. Org. Lett. 2005, 7, 167.
23. (f) Foltz, C.; Stecker, B.; Marconi, G.; Bellemin-Laponnaz, S.; Wadepohl, H.; Gabe, L. H. Chem. Commun. 2005, 5115.
24. (g) Xu, X.; Yabuta, T.; Yuan, P. Takemoto, Y. Synlett 2006, 137.
25. (h) Kim, Y. K.; Kim, D. Y. Tetrahedron Lett. 2006, 47, 4565.
26. (i) Terada, M.; Nakano, M.; Ube, H. J. Am. Chem. Soc. 2006, 128, 16044.
27. (j) Comelles, J.; Pericas, À.; Moreno-Mañas, M.; Vallribera, A.; Drudis-Solé, G.; Lledos, A.; Parella, T.; Roglans, A.; García-Granda, S.; Roces-Fernández, L. J. Org. Chem. 2007, 72, 2077.
28. (k) Hasegawa, Y.; Watanabe, M.; Gridnev, I. D.; Ikariya, T. J. Am. Chem. Soc. 2008, 130, 2158.
29. Mashiko, T.; Hara, K.; Tanaka, D.; Fujiwara, Y.; Kumagai, N.; Shibasaki, M. J. Am. Chem. Soc. 2007, 129, 11342.
30. Cu-Box, La-PyBox, urea-type organocatalyst, and cinchona alkaloids were screened in catalytic asymmetric amination of 1. The observed enantioselectivities were less than 30% ee. See also ref 6.
31. For recent selected examples of small peptide-based asymmetric catalysis, see:(a) Zhao, Y.; Rodrigo, J.; Hoveyda, A. H.; Snapper, M. C. Nature 2006, 443, 67.
32. (b) Lewis, C. A.; Chiu, A.; Kubryk, M.; Balsells, J.; Pollard, D.; Esser, C. K.; Murry, J.; Reamer, R. A.; Hansen, K. B.; Miller, S. J. J. Am. Chem. Soc. 2006, 128, 16454.
33. For reviews, see: (c) Hoveyda, A. H.; Hird, A. W.; Kacprzynski, M. A. Chem. Commun. 2004, 1779.
34. (d) Blank, J. T.; Miller, S. J. Biopolymers (Pept. Sci.) 2006, 84, 38.
35. Sigma-Aldrich Handbook of Fine Chemicals 2007-2008.
36. Bulk purchase may lower the cost.
37. For recent selected examples for the use of lanthanide nitrates for asymmetric catalysis, see:(a) Hamada, T.; Manabe, K.; Ishikawa, S.; Nagayama, S.; Shiro, M.; Kobayashi, S. J. Am. Chem. Soc. 2003, 125, 2989.
38. (b) Furuno, H; Hayano, T; Kambara, T; Sugimoto, Y; Hanamoto, T; Tanaka, Y; Jin, Y. Z; Kagawa, T; Inanaga, J. Tetrahedron 2003, 59, 10509.
39. Lanthanide niterates exhibit much less catalytic efficiency compared with corresponding triflates. RAJIV11For example, see: (c) Kano, S; Nakano, H; Kojima, M; Baba, N; Nakajima, K. Inorg. Chim. Acta 2003, 349, 6.
40. For selected examples of rare earth metal asymmetric catalyst showing enhanced stereoselectivity in the presence of amine, see:(a) Kobayashi, S.; Ishitani, H. J. Am. Chem. Soc. 1994, 116, 4083.
41. (b) Kobayashi, S.; Ishitani, H.; Hachiya, I.; Araki, M. Tetrahedron 1994, 50, 11623.
42. (c) Kobayashi, S.; Kawamura, M. J. Am. Chem. Soc. 1998, 120, 5840.
43. (d) Nishida, A.; Yamanaka, M.; Nakagawa, M. Tetrahedron Lett. 1999, 40, 1555.
44. (e) Furuno, H.; Hanamoto, T.; Sugimoto, Y.; Inanaga, J. Org. Lett. 2000, 2, 49.
45. (f) Fukuzawa, S.-I.; Komuro, Y.; Nakanao, N.; Obata, S. Tetrahedron Lett. 2003, 44, 3671.
46. 2O was calculated as x = 4.
47. A 25 g portion of di-tert-butyl azodicarboxylate was added five times during the first 5 min of the reaction. An additional 13.5 g was added 10 min after the last addition. The reaction was exothermic, and the reaction temperature varied from -5 to +8°C occasionally. The observed enantioselectivity was comparable to that obtained in small scale reactions likely because the enantioselectivity of the present amination is relatively insensitive to the reaction temperature.
48. Enantiomeric excess of 5 was determined after mono-Boc protection. See the Supporting Information for details.
49. (a) Metal Ions in Biological Systems: The Lathanides and Their Interrelations with Biosystems; Sigel, H., Sigel A., Eds; Marcel Dekker: New York, 2003; Vol. 40.
50. The Clarke number of lanthanum is 0.0018, almost equally abundant as zinc (0.004) or boron (0.001).